1-3 of 3
Sutapa Mukhopadhyay, PhD
Close
Sort by
Journal Articles

Time To Event Analyses in PANORAMA 2: A Phase 2 Study Of Panobinostat, Bortezomib, and Dexamethasone In Patients With Relapsed and Bortezomib-Refractory Multiple Myeloma

Paul G. Richardson, MD, Robert L. Schlossman, MD, Melissa Alsina, MD, Donna M. Weber, M.D., Steven E. Coutre, MD, Cristina Gasparetto, MD, Sutapa Mukhopadhyay, PhD, Michael S. Ondovik, PharmD, MBA, Mahmudul Khan, PhD, Carole S. Paley, MD, Sagar Lonial, M.D.
Journal: Blood
Blood (2013) 122 (21): 1970.
https://doi.org/10.1182/blood.V122.21.1970.1970
Published: 2013
Journal Articles

PANORAMA 2: Panobinostat Combined with Bortezomib and Dexamethasone in Patients with Relapsed and Bortezomib-Refractory Multiple Myeloma

Paul G. Richardson, MD, Melissa Alsina, MD, Donna Weber, MD, Steven E. Coutre, MD, Sagar Lonial, MD, Cristina Gasparetto, MD, Sutapa Mukhopadhyay, PhD, Michael Ondovik, PharmD, MBA, Mahmudul Khan, PhD, Carole Paley, MD, Robert Schlossman, MD
Journal: Blood
Blood (2012) 120 (21): 1852.
https://doi.org/10.1182/blood.V120.21.1852.1852
Published: 2012
Journal Articles

Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2)

Paul G. Richardson, MD, Melissa Alsina, MD, Donna M. Weber, MD, Steven E. Coutre, MD, Sagar Lonial, MD, Cristina Gasparetto, MD, Ghulam Warsi, PhD, Michael Ondovik, PharmD, MBA, Sutapa Mukhopadhyay, PhD, Susan Snodgrass, MD, Robert Schlossman, MD
Journal: Blood
Blood (2011) 118 (21): 814.
https://doi.org/10.1182/blood.V118.21.814.814
Published: 2011